19 October 2020 - Patients shut out of process leading to the release of revised guidelines by the Patented Medicine Prices Review Board.
As exciting medical advances continue to be made around the world, there is a shared concern that people in Canada will not be able to access these scientific breakthroughs.
Leading health charities and patient groups that represent 2.9 million patients across Canada are working together to raise concerns about revised guidelines expected by the Patented Medicine Prices Review Board (PMPRB) this week, that will limit access to treatments that could improve and even save lives.